Difference between revisions of "DZI19-121-Case-1"

@@ Line 1: / Line 1: @@
-{{dziSlide
+{{ServiceRequestCase
-|order_date=September 11, 2019 01:57:23 PM
+|identifier=DZI19-121-Case-1
-|user=Em99
+|intent=order
-|slide_stain=H&E
+|category=409073007
-|slide_anatomy=Show
+|priority=routine
+|orderDetail=case
+|locationCode=learn
+|basedOn=DZI19-121
+|code=faculty
+|supportingInfo=Integrated diagnosis: GLIOBLASTOMA, IDH-WILDTYPE
+Histological diagnosis: Glioblastoma
+WHO histological grade: IV
+Molecular information:
+IDH1: negative (R132H immunohistochemistry)
+MGMT promoter: methylated (methylation specific PCR)
+IHC for mutant ID1(R132H) was negative and is sufficient in patients >55 years of age to determine IDH status (rare to find non-canonical mutations in this group).
+|reasonCode=63 year old woman with a history of breast CA s/p bilateral mastectomy presents with difficulty walking, staggering gait, and fatigue
+|subject=MGH
+|performer=MML55
+|authoredOn=September 11, 2019 01:57:23 PM
+|requester=Em99
+|sequence=1
+|access=public
 }}
-{{dziCase
+{{Media
-|order_date=September 11, 2019 01:57:23 PM
+|basedOn=DZI19-121-Case-1
-|user=Em99
+|type=image
-|dziorder=DZI19-121
+|view=show
-|case_id=1
+|partOf=DZI19-121
-|clinical_hx=63 year old woman with a history of breast CA s/p bilateral mastectomy presents with difficulty walking, staggering gait, and fatigue
+|frames=1
-|gross=[[File:Case 1.png|thumb|MRI: T1 coronal post gadolinium shows a large mass with irregular peripheral contrast enhancement]]
+|reasonCode=H&E
+|identifier=DZI19-121-Case-1_1
+|createdDateTime=September 11, 2019 01:57:23 PM
+|operator=Em99
+|modality=ndpi
 }}
-{{dziMedia
+{{status
-|order_date=September 13, 2019 05:44:47 PM
+|status=active
-|user=Em99
+|requester=Em99
-|media_filename=Case_1.png
+|authoredOn=September 11, 2019 01:57:23 PM
-|media_text=MRI: T1 coronal post gadolinium shows a large mass with irregular peripheral contrast enhancement
 }}

Difference between revisions of "DZI19-121-Case-1"

Latest revision as of 13:23, December 9, 2024